Efficacy and Safety of Different Norepinephrine Regimens for Prevention of Spinal Hypotension in Cesarean Section: A Randomized Trial

Table 5

Adverse effects.

	Control	NE1	NE2	NE3	value
Shivering	8 (26.7%, 9.9%–43.5%)	4 (13.8%, 0.4%–27.1%)	4 (13.3%, 0.4%–26.2%)	7 (25.0%, 7.9%–42.1%)	0.419
Nausea	5 (16.7%, 2.5%–30.8%)	2 (6.9%, 0%–16.7%)	3 (10.0%, 0%–21.4%)	5 (17.9%, 2.7%–33%)	0.541
Pale skin	1 (3.3%, 0%–10.2%)	1 (3.4%, −3.6%–10.5%)	6 (20.0%, 4.8%–35.2%)	3 (10.7%, 0%–22.9%)	0.089
Bradycardia	0 (0.0%, 0.0%–0.0%)	1 (3.4%, 0%–10.5%)	1 (3.3%, 0%–10.2%)	3 (10.7%, 0%–22.9%)	0.232

Data were presented as number (percentage, 95% confidence interval).